Literature DB >> 3018361

Tetrahydrocannabinol stability in whole blood: plastic versus glass containers.

A S Christophersen.   

Abstract

The stability of tetrahydrocannabinol (THC) in whole blood during storage was investigated. Two types of containers were used: plastic tubes (polystyrene) and glass vials. Freshly drawn blood was spiked with 10 pmol THC/mL and stored for four days at room temperature (20 degrees to 25 degrees C). The material was kept for four weeks at -20 degrees C. Blood samples from 16 persons apprehended by the police on suspicion of cannabis smoking were collected into the two types of containers and stored frozen (-20 degrees C) until analysis. THC was quantified by capillary column gas chromatography/electron impact mass spectrometry (GC/EI-MS) combined with selected ion monitoring (SIM). Deuterium-labeled THC (THC-d3) was used as internal standard (IS) and was added to the samples immediately prior to extraction. The THC level remained unchanged in glass vials. Samples from the plastic containers had lost 60 to 100% of their THC during storage. In 13 authentic samples, the THC level in blood from the plastic containers varied 0 to 87% from the level in the same blood stored in glass vials. The IS was undetectable in some of these samples.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018361     DOI: 10.1093/jat/10.4.129

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  14 in total

1.  Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.

Authors:  Ketan Hippalgaonkar; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

2.  Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.

Authors:  David M Schwope; Erin L Karschner; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2011-08-11       Impact factor: 8.327

3.  Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry.

Authors:  Karl B Scheidweiler; Nathalie A Desrosiers; Marilyn A Huestis
Journal:  Clin Chim Acta       Date:  2012-07-06       Impact factor: 3.786

4.  Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.

Authors:  Thitirat Ngaotepprutaram; Barbara L F Kaplan; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-30       Impact factor: 4.219

Review 5.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

6.  Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.

Authors:  Tushar Hingorani; Waseem Gul; Mahmoud Elsohly; Michael A Repka; Soumyajit Majumdar
Journal:  J Pharm Sci       Date:  2011-10-11       Impact factor: 3.534

7.  Cannabis and cardiotoxicity.

Authors:  Steven B Karch
Journal:  Forensic Sci Med Pathol       Date:  2006-03       Impact factor: 2.007

8.  Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing.

Authors:  Eugene W Schwilke; Erin L Karschner; Ross H Lowe; Ann M Gordon; Jean Lud Cadet; Ronald I Herning; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-03-05       Impact factor: 8.327

9.  Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?

Authors:  Erin L Karschner; Eugene W Schwilke; Ross H Lowe; W David Darwin; Harrison G Pope; Ronald Herning; Jean L Cadet; Marilyn A Huestis
Journal:  Addiction       Date:  2009-10-05       Impact factor: 6.526

10.  In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.

Authors:  Karl B Scheidweiler; David M Schwope; Erin L Karschner; Nathalie A Desrosiers; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-03-21       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.